GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » BIO-key International Inc (NAS:BKYI) » Definitions » Return-on-Tangible-Equity

BIO-key International (BIO-key International) Return-on-Tangible-Equity : -126.37% (As of Sep. 2023)


View and export this data going back to 1997. Start your Free Trial

What is BIO-key International Return-on-Tangible-Equity?

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. BIO-key International's annualized net income for the quarter that ended in Sep. 2023 was $-2.55 Mil. BIO-key International's average shareholder tangible equity for the quarter that ended in Sep. 2023 was $2.02 Mil. Therefore, BIO-key International's annualized Return-on-Tangible-Equity for the quarter that ended in Sep. 2023 was -126.37%.

The historical rank and industry rank for BIO-key International's Return-on-Tangible-Equity or its related term are showing as below:

BKYI' s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -3020.5   Med: -129.11   Max: -32.52
Current: -250.85

During the past 13 years, BIO-key International's highest Return-on-Tangible-Equity was -32.52%. The lowest was -3,020.50%. And the median was -129.11%.

BKYI's Return-on-Tangible-Equity is ranked worse than
98% of 998 companies
in the Business Services industry
Industry Median: 12.135 vs BKYI: -250.85

BIO-key International Return-on-Tangible-Equity Historical Data

The historical data trend for BIO-key International's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BIO-key International Return-on-Tangible-Equity Chart

BIO-key International Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Return-on-Tangible-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only -150.69 -3,020.50 -129.11 -33.21 -143.97

BIO-key International Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -116.31 -507.59 -32.85 -199.02 -126.37

Competitive Comparison of BIO-key International's Return-on-Tangible-Equity

For the Security & Protection Services subindustry, BIO-key International's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BIO-key International's Return-on-Tangible-Equity Distribution in the Business Services Industry

For the Business Services industry and Industrials sector, BIO-key International's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where BIO-key International's Return-on-Tangible-Equity falls into.



BIO-key International Return-on-Tangible-Equity Calculation

BIO-key International's annualized Return-on-Tangible-Equity for the fiscal year that ended in Dec. 2022 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Dec. 2022 )  (A: Dec. 2021 )(A: Dec. 2022 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Dec. 2022 )  (A: Dec. 2021 )(A: Dec. 2022 )
=-11.91/( (13.006+3.539 )/ 2 )
=-11.91/8.2725
=-143.97 %

BIO-key International's annualized Return-on-Tangible-Equity for the quarter that ended in Sep. 2023 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Sep. 2023 )  (Q: Jun. 2023 )(Q: Sep. 2023 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Sep. 2023 )  (Q: Jun. 2023 )(Q: Sep. 2023 )
=-2.552/( (2.245+1.794)/ 2 )
=-2.552/2.0195
=-126.37 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Sep. 2023) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.


BIO-key International  (NAS:BKYI) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


BIO-key International Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of BIO-key International's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


BIO-key International (BIO-key International) Business Description

Traded in Other Exchanges
N/A
Address
3349 Highway 138, Building A, Suite E, Wall, NJ, USA, 07719
BIO-key International Inc is a fingerprint biometric technology company. It develops and markets advanced fingerprint biometric identification and identity verification technologies, as well as related identity management and credentialing hardware and software solutions. Its product portfolio comprises SideSwipe, SidePass, EcoID, WEB-key, and others. The company generates its revenue in the form of Services, License fees, and others.
Executives
Michael W Depasquale director, officer: Co-Chief Executive Officer 1285 CORPORATE CENTER DR, STE 175, EAGAN MN 55121
James David Sullivan officer: See Remarks 411 WALNUT ST., PMB #15855, GREEN COVE SPRINGS FL 32043
Cameron E. Williams director 400 N. CASCADES CIRCLE, CANTON GA 30114
Fong Wong Kwok director FLAT C, 27/F., BLOCK 5, GRAND PACIFIC VIEWS, SIU LAM K3 00000
Emmanuel Alia director 15 C SIGNAL HILL ROAD, MADISON CT 06443
Robert J Michel director C/O ASTA FUNDING, INC., 210 SYLVAN AVENUE, ENGLEWOOD CLIFFS NJ 07632
Micron Technology Development Ltd 10 percent owner 5/F., SPA CENTRE, 53-55 LOCKHART ROAD, WANCHAI K3 999077
Yick Fabian Shin director FLAT B, 23/F, TOWER 2B, 19 TONG YON ST.,, THE WINGS IIIA, TSEUNG KWAN O., NEW TERRITORIES K3 00000
Knook Pieter Cornelis director 3349 HIGHWAY 138, BUILDING A, SUITE E, WALL NJ 07719
Jianhui Yao director SUITES 2601-2, 26/F TOWER 2, NINA TOWER, 8 YEUNG UK RD, TSUEN WAN K3 TWTL 353
Barbara Rivera director C/O BIO-KEY INTERNATIONAL, INC., 3349 HIGHWAY 138, BUILDING A, SUITE E, WALL NJ 07719
Thomas Gilley director C/O BIO-KEY INTERNATIONAL, INC., 3349 HIGHWAY 138, BUILDING A, SUITE E, WALL NJ 07719
Iii Thomas Bush, director C/O BIO-KEY INTERNATIONAL, INC., 3349 HIGHWAY 138, BUILDING A, SUITE E, WALL NJ 07719
Cecilia C Welch officer: Chief Financial Officer PO BOX 588, DUNSTABLE MA 01827
John Schoenherr director C/O ORACLE CORPORATION, 10 VAN DE GRAAFF DRIVE, BURLINGTON MA 01803

BIO-key International (BIO-key International) Headlines

From GuruFocus